Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Cancer and Leukemia Group B | NETWORK |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is being done to determine whether a telephone-based counseling intervention can help survivors of breast and colorectal cancer increase their weekly physical activity. Observational evidence suggests that physical activity after breast and colorectal cancer diagnosis decreases recurrence rates. Unfortunately, many people become less active during cancer therapy, and a substantial proportion never return to pre-diagnosis levels of physical activity. This study looks to see if people who have recently finished chemotherapy for breast, colon or rectal cancer can be motivated to increase their exercise by talking to an exercise specialist over the phone. The study also looks at changes in mood, fatigue, fitness, fat distribution and weight.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | Immediate participation in a 16-week exercise program |
|
| 2 | No Intervention | Control population; will receive exercise plan after 16-week control period |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telephone-Based exercise intervention | Behavioral | Exercise counselling offered via telephone calls |
|
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate the ability of a multi-center, telephone-based physical activity intervention to increase weekly physical activity levels in sedentary patients treated with adjuvant chemotherapy for Stage I-III breast or colorectal cancer. | months |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate the impact of a physical activity intervention upon fitness, exercise self-efficacy, anthropometric measures, and quality of life in a group of patients with stage I-III breast or colorectal cancer. | months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jennifer Ligibel, MD | Dana-Farber Cancer Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California at San Diego | La Jolla | California | 92093 | United States | ||
| University of California San Francisco |
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| San Francisco |
| California |
| 94143 |
| United States |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | United States |
| New Hampshire Oncology Hematology | Concord | New Hampshire | 03106 | United States |
| Lakes Regional Healthcare Hematology Oncology | Hooksett | New Hampshire | 03106 | United States |
| Rosewell Park Cancer Institute | Buffalo | New York | 14263 | United States |
| Hematology Oncology Associates of Central New York | East Syracuse | New York | 13057 | United States |
| Ohio State University | Columbus | Ohio | 43210 | United States |
| Vermont Cancer Center | Burlington | Vermont | 05401 | United States |
| D017437 |
| Skin and Connective Tissue Diseases |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |